|Stanford University Graduate School of Business, M.B.A.|
|University of Cambridge, BA|
Thomas Farrell joined Bellicum in February 2006. He has a twelve year track record as a serial life science entrepreneur. Prior to joining Bellicum, he was founding President & CEO of San Diego-based Cylene Pharmaceuticals, a venture-backed company developing a novel class of small molecules as anti-cancer therapy, targeting secondary DNA structures and associated kinases. He received his M.B.A. at Stanford Graduate School of Business, where he was an Arjay Miller Scholar.